Drug Delivery
Title Abbreviation
Drug Deliv
Electronic ISSN
1521-0464
Readership
Academics, Cell Biologists, Chemists, Clinicians, Industrial Scientists, Molecular Biologists, Pathologists, Pharmacologists, Physiologists, Researchers, Scientists
Scope
Drug Delivery publishes open access peer-reviewed research on the development and application principles of drug delivery and targeting at molecular, cellular, and higher levels.
Drug Delivery aims to serve both the academic and industrial communities and accepts research on the following topics: All drug delivery systems, including oral, pulmonary, nasal, parenteral and transdermal delivery; All modes of drug entry, such as controlled release systems; Microcapsules, liposomes, vesicles, and macromolecular conjugates; Antibody targeting; Protein/peptide delivery; DNA, oligonucleotide and siRNA delivery.
Papers on drug dosage forms and their optimization will not be considered unless they directly relate to the original drug delivery issues listed above.
The journal publishes both original research and critical reviews. Drug Delivery operates a single-blind peer review policy.
Sponsoring Association(s)
No associations affiliated with this journal
Publisher Name
Taylor & Francis, Inc. - UK
Impact Factor
JCR Categories/Rank
Circulation
Electronic Circulation
Submission to Acceptance
Acceptance to Online Publication
Rejection Rate
Frequency
Journal Contact
Author Submission Guidelines